Tag: Regeneron Pharmaceuticals
Top 20 biopharma cos report fall in market capitalization
Expanding competition in the generic drugs segment and a decline in the demand for Covid-19 vaccines and therapies have brought down the aggregate market...
Sanofi and Regeneron provide update on Kevzara Phase 3 Covid-19 trials
Sanofi and Regeneron Pharmaceuticals announced that the US Phase 3 trial of Kevzara (sarilumab) 400 mg in Covid-19 patients requiring mechanical ventilation did not...